Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand

This article was originally published in The Pink Sheet Daily

Executive Summary

Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.

You may also be interested in...



Tamiflu Drags On Roche’s First Quarter Sales

Sales of Rituxan, Herceptin, Avastin and Boniva increase by double digits.

Tamiflu Drags On Roche’s First Quarter Sales

Sales of Rituxan, Herceptin, Avastin and Boniva increase by double digits.

Roche Hedges On U.S. Launch Of Mircera With November FDA Action Date Expected

Decision in Amgen’s patent infringement case against Roche over the continuous erythropoiesis receptor activator is expected in October.

Related Content

Topics

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel